International Journal of Surgery10.1016/j.ijsu.2012.06.2052012108S39Survival rates for patients with anaplastic thyroid carcinoma receiving different treatment modalities.Natalie Lowe, Beng Yap,
Journal of Korean Society of Endocrinology10.3803/jkes.2005.20.2.1272005202127The Effect of Treatment Modalities on Survival Rates of Patients with Anaplastic Thyroid CarcinomaJae Myoung Choi, Mi Jeong Kim, Seung Won Lee, Kyoung Eun Song, Yoon-Sok Chung, Kwan Woo Lee, Dae Jung Kim, Sung Hee Choi, So Hun Kim, Min Ho Cho, Yumie Rhee, Chul Woo Ahn, Sung Kil Lim, Kyung Rae Kim,,
Cancer10.1002/cncr.31252201812481780-1790Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancerAnsley M. Roche, Stacey A. Fedewa, Lucy L. Shi, Amy Y. Chen,
European Journal of Cancer Supplements10.1016/s1359-6349(05)81350-32005323041055 POSTER Multimodality treatment for anaplastic thyroid carcinoma — does it improve survival?,
European Journal of Surgical Oncology (EJSO)10.1053/ejso.2000.10982001273260-264Effect of primary treatment on survival in anaplastic thyroid carcinomaN. Besic, M. Auersperg, M. Us-Krasovec, R. Golouh, S. Frkovic-Grazio, A. Vodnik,
European Journal of Cancer10.1016/s0959-8049(99)81261-1199935S212Primary treatment and survival in anaplastic thyroid carcinomaN. Bešić, M. Auersperg, M. Us-Krašovec, R. Golouh, E. Brecelj,
Thyroid Diseases10.1007/978-3-319-45013-1_232018629-643Anaplastic and Other Forms of Thyroid CarcinomaLeonard Wartofsky
Advances in Genomics and Genetics10.2147/agg.s53448201543Anaplastic thyroid cancer – an overview of genetic variations and treatment modalitiesHoney Reddi, Anirudh Kumar, Roger Kulstad
Thyroid10.1089/thy.2000.10.5872000107587-594Treatment of Anaplastic Thyroid Carcinoma with Paclitaxel: Phase 2 Trial Using Ninety-Six-hour InfusionKenneth B. Ain, Merrill J. Egorin, Philip A. DeSimone,
Imaging in Otolaryngology10.1016/b978-0-323-54508-2.50077-72018106Anaplastic Thyroid Carcinoma,